Veterinary Biologics Market: By Product Type (Vaccines, Diagnostic Kits, Antibody Products, Others), By Disease (Bluetongue, Aujeszky's Disease, Bovine Viral Diarrhea, Bovine Tuberculosis, Clostridial Disease, Foot and Mouth Disease, Others), By Species (Poultry, Bovine, Aquatic, Porcine, Others), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Veterinary Biologics Market size was valued at USD 11.2 billion in 2022, growing at a CAGR of 7.1% during the forecast period 2023-29 . Global veterinary biologics market is primarily driven by increase in demand for food security around the world and initiatives by the various government and non-government organizations to vaccinate the animals. The veterinary biologics industry is currently highly concentrated, with prominent firms such as Zoetis, Boehringer Ingelheim, Ceva, Elanco Animal Health, and Merck Animal Health accounting for two-thirds of the revenue share. These companies are increasingly delegating their innovation to startups and other collaborators with superior genomics and biotech knowledge. Furthermore, increasing investments in veterinary science and multi-disciplinary vaccinology research are projected to propel the veterinary biologics market to new heights. In light of growing livestock production and booming pet product sales, a major transformation in the animal health business will further create a window of growth potential. The growing number of veterinary clinics in both developed and emerging countries, which account for 2/5 of total revenue, is driving demand for veterinary biologics. Market participants are directing their product sales through retail pharmacies in order to boost their profit margins and regional presence. Increased government emphasis on the unification of research in veterinary pharmaceuticals and human medicine can also be attributable to significant rise in veterinary biologics sales through these channels. However, a major gap in understanding the epidemiology pattern of animal diseases remains a potential hazard to market participants. As illnesses evolve, vaccination research and development has been ramped up to protect animals from new strains. Veterinary biologics, such as monoclonal antibodies and immunomodulators, will also see advancements.

Global Veterinary Biologics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.1%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Veterinary Biologics Market Dynamics Dynamics

Growing demand for meat and rise in trend towards adaptation of companion animals in developing countries projected to boost the market share. Moreover, increase in company investments to produce advanced and novel veterinary biologics coupled with growing animal health concerns expected to bolster the global veterinary biologics market. However, lack of knowledge in some of the virulent veterinary diseases and regulatory procedures are expected to impede the global market over the forecast period

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Veterinary Biologics Market Segmentation

By Product Type
  • Vaccines
  • Antibody Products
  • Immunomodulators
  • Others
By Disease
  • Bluetongue
  • Aujeszky's Disease
  • Bovine Viral Diarrhea
  • Bovine Tuberculosis
  • Clostridial Disease
  • Foot and Mouth Disease
  • Others
By Species
  • Poultry
  • Bovine
  • Aquatic
  • Porcine
  • Others

Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Veterinary Biologics Market size was valued at USD 11.2 billion in 2022, growing at a CAGR of 7.1% during the forecast period 2023-29.

The key opportunities for the veterinary biologics market include growing pet ownership, increasing awareness of animal health, and a rising demand for effective vaccines and biopharmaceuticals to address emerging diseases in animals.

1.Executive Summary
2.Global Veterinary Biologics Market Introduction 
2.1.Global Veterinary Biologics Market  - Taxonomy
2.2.Global Veterinary Biologics Market  - Definitions
2.2.1.Product Type
2.2.2.Disease
2.2.3.Species
2.2.4.Region
3.Global Veterinary Biologics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Veterinary Biologics Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Veterinary Biologics Market  By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Vaccines
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Antibody Products
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Immunomodulators
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Veterinary Biologics Market  By Disease, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Bluetongue
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Aujeszky's Disease
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Bovine Viral Diarrhea
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Bovine Tuberculosis
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Clostridial Disease
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Foot and Mouth Disease
6.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Others
6.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
7.Global Veterinary Biologics Market  By Species, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Poultry
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Bovine
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Aquatic
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Porcine
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Others
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.Global Veterinary Biologics Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Veterinary Biologics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Vaccines
9.1.2.Antibody Products
9.1.3.Immunomodulators
9.1.4.Others
9.2.  Disease Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Bluetongue
9.2.2.Aujeszky's Disease
9.2.3.Bovine Viral Diarrhea
9.2.4.Bovine Tuberculosis
9.2.5.Clostridial Disease
9.2.6.Foot and Mouth Disease
9.2.7.Others
9.3.  Species Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Poultry
9.3.2.Bovine
9.3.3.Aquatic
9.3.4.Porcine
9.3.5.Others
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Veterinary Biologics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Vaccines
10.1.2.Antibody Products
10.1.3.Immunomodulators
10.1.4.Others
10.2.  Disease Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Bluetongue
10.2.2.Aujeszky's Disease
10.2.3.Bovine Viral Diarrhea
10.2.4.Bovine Tuberculosis
10.2.5.Clostridial Disease
10.2.6.Foot and Mouth Disease
10.2.7.Others
10.3.  Species Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Poultry
10.3.2.Bovine
10.3.3.Aquatic
10.3.4.Porcine
10.3.5.Others
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
10.4.7.
11.Asia Pacific (APAC) Veterinary Biologics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Vaccines
11.1.2.Antibody Products
11.1.3.Immunomodulators
11.1.4.Others
11.2.  Disease Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Bluetongue
11.2.2.Aujeszky's Disease
11.2.3.Bovine Viral Diarrhea
11.2.4.Bovine Tuberculosis
11.2.5.Clostridial Disease
11.2.6.Foot and Mouth Disease
11.2.7.Others
11.3.  Species Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Poultry
11.3.2.Bovine
11.3.3.Aquatic
11.3.4.Porcine
11.3.5.Others
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Veterinary Biologics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Vaccines
12.1.2.Antibody Products
12.1.3.Immunomodulators
12.1.4.Others
12.2.  Disease Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Bluetongue
12.2.2.Aujeszky's Disease
12.2.3.Bovine Viral Diarrhea
12.2.4.Bovine Tuberculosis
12.2.5.Clostridial Disease
12.2.6.Foot and Mouth Disease
12.2.7.Others
12.3.  Species Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Poultry
12.3.2.Bovine
12.3.3.Aquatic
12.3.4.Porcine
12.3.5.Others
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Veterinary Biologics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Vaccines
13.1.2.Antibody Products
13.1.3.Immunomodulators
13.1.4.Others
13.2.  Disease Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Bluetongue
13.2.2.Aujeszky's Disease
13.2.3.Bovine Viral Diarrhea
13.2.4.Bovine Tuberculosis
13.2.5.Clostridial Disease
13.2.6.Foot and Mouth Disease
13.2.7.Others
13.3.  Species Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Poultry
13.3.2.Bovine
13.3.3.Aquatic
13.3.4.Porcine
13.3.5.Others
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Zoetis, Inc. (U.S.)
14.2.2.ElancoAnimal Health (Eli Lilly and Company) (U.S.)
14.2.3.Merial (C.H. BoehringerSohn AG & Co. KG) (Germany)
14.2.4.Merck & Co., Inc. (U.S.)
14.2.5.Bayer AG (Germany)
14.2.6.CevaSanteAnimale S.A. (France)
14.2.7.Virbac (France)
15. Research Methodology 
16. Appendix and Abbreviations 
  • Zoetis, Inc. (U.S.)
  • ElancoAnimal Health (Eli Lilly and Company) (U.S.)
  • Merial (C.H. BoehringerSohn AG & Co. KG) (Germany)
  • Merck & Co., Inc. (U.S.)
  • Bayer AG (Germany)
  • CevaSanteAnimale S.A. (France)
  • Virbac (France)